Tribulations and trials in HIV disease, Part 2.
Boyle
Brian A
BA
Department of International Medicine and Infectious Diseases, New York Presbyterian Hospital-Weill Medical College of Cornell University, New York, USA.
D019380:Anti-HIV Agents / Q000494:pharmacology / Q000627:therapeutic use*; D065100:CCR5 Receptor Antagonists; D002986:Clinical Trials as Topic; D000069454:Darunavir; D015658:HIV Infections / Q000188:drug therapy* / Q000235:genetics; D019428:HIV Integrase Inhibitors / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use; D017320:HIV Protease Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D013449:Sulfonamides / Q000494:pharmacology / Q000627:therapeutic use
D019380:Anti-HIV Agents; D065100:CCR5 Receptor Antagonists; D019428:HIV Integrase Inhibitors; D017320:HIV Protease Inhibitors; D013449:Sulfonamides; D000069454:Darunavir